Navigation Links
New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
Date:5/30/2009

- Several SSRIs more than double risk of cancer recurrence in tamoxifen treated patients

- Nearly 30 percent of tamoxifen users take drugs that reduce its effectiveness against breast cancer

ORLANDO, Fla., May 30 /PRNewswire-FirstCall/ -- An important new study finds that certain popular antidepressants frequently prescribed to women taking the breast cancer drug tamoxifen more than double the risk of a breast cancer recurrence for those using both medications. The research presented by Medco Health Solutions, Inc. (NYSE: MHS) and Indiana University School of Medicine at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) is the largest study to date looking at how these drugs impact breast cancer recurrence rates when taken with tamoxifen.

The antidepressants at issue are three widely used selective serotonin reuptake inhibitors (SSRIs), Prozac(R) (fluoxetine), Paxil(R) (paroxetine) and Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 inhibitors. Antidepressants are often prescribed with tamoxifen to treat depression - a common co-morbidity of the disease, as well as hot flashes - a common side-effect of the breast cancer drug.

The three drugs that pose this risk for women on tamoxifen are considered to be moderate to potent CYP2D6 inhibitors. Several other SSRIs examined in the study that are weak CYP2D6 inhibitors did not raise breast cancer recurrence risks for patients using them along with tamoxifen. Those SSRIs included Celexa(R) (citalopram), Lexapro(R) (escitalopram) and Luvox(R) (fluvoxamine).

"We've known that these CYP2D6 inhibitor drugs block the activation of tamoxifen chemically, but this is the first time there's evidence that these drugs are putting women at a much higher risk for recurrent breast cancer
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study: Pine Bark Significantly Reduces Menstrual Pain
2. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
3. New Research Shows Antidepressants May Thwart Breast Cancer Treatment
4. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
7. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
8. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
9. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
10. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
11. Methadone Frequently Causes Menopausal Symptoms in Young Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... ATLANTA , March 30, 2015  Edelberg ... the first of its kind, real-time medical coding ... the patient, physician, scribe and medical coder at ... lengthy collaboration initiative with ScribeAmerica, EA has successfully ... method for real-time interaction between scribe and medical ...
(Date:3/30/2015)... Calif. , March 30, 2015 ... that it has initiated a multi-dose Phase 1 ... the lead molecule in DURECT,s Epigenomic Regulator Program.  ... (NCE) that may have broad applicability in metabolic ... and nonalcoholic steatohepatitis (NASH).  It may also play ...
(Date:3/30/2015)... March 30, 2015   GlassesUSA , the online retailer ... $12.5 million in new financing led by Viola Private ... will further GlassesUSA,s aggressive business growth and accelerate their expansion ... online eyewear, both B2C and B2B. GlassesUSA was ... Eldad Rothman , and CTO Roy Yamner . ...
Breaking Medicine Technology:Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... 16, 2010 New results from an observational ... American Heart Association (AHA) Scientific Sessions annual meeting ... to coronary artery bypass graft surgery (CABG) had ... treated with Plavix® (clopidogrel) (2.3 percent versus 8.7 ...
... Decision Resources, one of the world,s leading research ... that, owing to the launch of several novel agents, ... than triple from approximately $2 billion in 2009 to ... France, Germany, Italy, Spain, the United Kingdom and Japan. ...
Cached Medicine Technology:Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 2Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 3Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 4Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 5Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery 6The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 2The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments 3
(Date:3/30/2015)... 30, 2015 Wright & Schulte LLC, ... notes that the number of Syngenta corn lawsuits ... in U.S. District Court, District of Kansas, have risen ... "According to an update released by the U.S. Judicial ... least 493 Syngenta lawsuits are now consolidated in the ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A new ... in California Superior Court on behalf of a child ... defect after his mother was prescribed the anti-nausea medication ... March 6th filing in Alameda Superior Court, the baby’s ... vomiting that she experienced in the early months of ...
(Date:3/30/2015)... 30, 2015 On March 11, 2015, Elle ... Away Fat,” details six new treatment options for dealing with ... one is a topical product. The other three technologies use ... Liposonix ) or freezing cold ( CoolSculpting ) to kill ... now available to us to permanently remove unwanted fat," says ...
(Date:3/30/2015)... In a recent report published by ... Christie is championing effective drug and alcohol treatment for ... to recover funds to stabilize the addiction treatment programs, ... of drug and alcohol addiction. Harbor Village Detox is ... substance use disorders in New Jersey, in hopes to ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 This ... software market over the forecast period of 2014 ... at a CAGR of 6.5% from 2014 to ... , In this report, the global pharmacovigilance and ... many segments on the basis of functionality, namely, ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... and cursed: the Stanev gypsy family parted with their three ... European Union, rescued this week from years of abuse . ... our bears, our kids?" a tearful Velichka Staneva, 58, cried ... son, Veselin, led out his 19-year-old male bear Misho and ...
... Tens of thousands Saturday staged the Gay Pride parade ... to grant homosexual couples legal status and override Vatican ... which included transvestites and lawmakers, marched under a baking ... of Saint John Lateran, the official ecclesiastical seat of ...
... been together for 18 years, and rocker Jon Bon Jovi insists ... another woman. ,Jovi, who has seen the collapse ... Richie Sambora, insists that his wife is really something special to ... that he's 'had his lapses'. ,"I wouldn't trade her in ...
... Jessica Alba prefers a hot one-night stand to being in ... magazine, admitted that she doesn't think that one-night stands or ... that she has indulged in several one-night trysts. ,"I ... with different people. I don't think a girl's a sl*t ...
... England's top footballers woke up as married men Sunday ... ultimate WAG wedding weekend. ,The off-field antics ... of England's footballers were as much the focus as ... World Cup. And there was an almighty fixture pile-up ...
... expensive technique for mutating those large, non-gene stretches of DNA. ... human genetic blueprint , yet diseases can result not only ... controls genes. ,Diseases are known to occur as ... method allows us to evaluate what these sequences do, says ...
Cached Medicine News:Health News:Europe's Last Dancing Bears Sheltered After Years of Abuse 2Health News:Gay Pride Attracts Tens of Thousands in Rome 2Health News:WAG Wedding Extravaganza for England Footballers 2Health News:Genome Annotation by Mutation 2Health News:Genome Annotation by Mutation 3Health News:Genome Annotation by Mutation 4Health News:Genome Annotation by Mutation 5
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
McPherson curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 85 mm....
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Medicine Products: